MYC and cancer: We therefore invite future studies interrogating mechanisms by which FUBP1/Psi, FIR/Hfp and B52 sense the cellular signaling environment and how these factors modulate MYC promoter architecture to control cell and tissue growth during development, as these will shed light on MYC-dysregulation in cancer.